KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.
Surgical & Medical Instruments & Apparatus
- Revenue
- $95M
- 59% YoY
- Operating margin
- -141.6%
- 20% YoY
- EBITDA
- −$126M
- 28% YoY
- Market cap
- $1.8B
- Employees
- 443
- $215K revenue each
- Net debt / EBITDA
- —
- $4M net debt
- AI in 10-K
- 0.4
- mentions per 10K words
Takeover score 5 of 13
Fixable underperformance 1 of 7
- TSR below peersNo—3+ of last 5 years
- High CEO pay despite TSRNo—Median CEO pay ≥ $15M while TSR trails
- Earnings not backed by cashNo—Cash flow under 80% of net income
- Dilutive SBCYes35% of revenueOver 10% of revenue
- Payouts exceed cash flowNo0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyNo—Over 40% of assets
- Shareholder dissentNo100% lowest supportAny vote under 80% support
Buyer economics 3 of 4
- Low revenue per employeeYes$215K · 14th pctBottom quartile of its SIC industry
- Quiet on AIYes0.4 per 10K words · 19th pctBottom quartile of AI mentions in 10-Ks
- Net cashNo—More cash than debt, positive EBITDA
- Buyout-sizedYes$1.8B market capMarket cap $500M–$5B
Catalysts 1 of 2
- Active 13DNo0 filingsActive-intent 13D in 18 months
- Net insider sellingYes−$15M netNet sales over $10M in 12 months
Financials
| Metric | FY2024 | FY2025 | FY2026 | YoY |
|---|---|---|---|---|
| Revenue | $28M | $60M | $95M | 59% |
| Operating income | −$85M | −$106M | −$135M | 27% |
| Net income | −$94M | −$114M | −$132M | 16% |
| Operating cash flow | −$72M | −$78M | −$82M | 5.3% |
| Capex | $12M | $23M | $35M | 52% |
| Stock-based comp | $1M | $24M | $34M | 39% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $200K · 1
- Open-market sells, 12 mo
- $15M · 53
- Net
- −$15M
Pay vs performance
No pay-versus-performance disclosure yet.